These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2961645)

  • 1. [Role of DA2 peripheral receptors in the regulation of blood pressure in elderly hypertensive patients: effects of dihydroergotoxine mesylate and sulpiride].
    Lombardi C; De Cotiis R; Spedini C
    G Clin Med; 1987; 68(8-9):421-5. PubMed ID: 2961645
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives.
    Lombardi C; De Cotiis R; Spedini C; Missale C; Memo M; Spano PF
    Eur J Clin Pharmacol; 1987; 33(5):519-21. PubMed ID: 2962878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DA2-type dopamine receptors: the physiological and clinical implications in cardiology].
    Mercuro G; Rivano CA; Lai L; Longu G; Cherchi A
    Cardiologia; 1987 Dec; 32(12):1623-30. PubMed ID: 2965981
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral dopamine receptors in the antihypertensive action of dihydroergotoxine in humans.
    Mercuro G; Rossetti ZL; Rivano CA; Ruscazio M; Tocco L; Gessa G; Cherchi A
    Hypertension; 1987 Jan; 9(1):35-40. PubMed ID: 3793199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of central dopamine (DA) receptors in the regulation of blood pressure.
    Jaszlits L; Tardos L; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):405-10. PubMed ID: 4070082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine in the pathogenesis of hypertension.
    Jose PA; Eisner GM; Felder RA
    Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S10-3. PubMed ID: 10386248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Co-dergocrinmesylate in elderly hypertensive patients].
    Bock KD; Welzel D; Dennler HJ
    MMW Munch Med Wochenschr; 1982 Dec; 124(48):1095-8. PubMed ID: 6817133
    [No Abstract]   [Full Text] [Related]  

  • 8. The dopaminergic system in hypertension.
    Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
    Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroergotoxine decreases blood pressure in spontaneously hypertensive rats by interacting with peripheral dopamine receptors.
    Memo M; Sagheddu G; Carruba MO; Spano P
    Life Sci; 1985 Apr; 36(16):1515-22. PubMed ID: 3982223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies.
    Guffanti E; Vaccarella A; Meregalli M; Fiorella G; Chierichetti SM; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):506-9. PubMed ID: 3902677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Careful treatment of hypertension in the elderly. A multicenter medical practice study with Ergodesit Spezial].
    Daunderer W
    Fortschr Med; 1985 Jul; 103(25):680-2. PubMed ID: 4029863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of dopamine receptors in the mechanism of formation of stress-induced stomach lesions].
    Groĭsman SD; Karevina TG; Khokholia VP
    Biull Eksp Biol Med; 1984 Jan; 97(1):57-60. PubMed ID: 6229292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H; Majewski H; Hedler L; Starke K
    J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of dihydroergotoxin (Redergin tablets, 4.5 mg) on blood pressure and left ventricular function in patients with essential hypertension].
    Kocijancic M; Sisić I; Zlatar D; Ivanković D
    Med Pregl; 1985; 38(1-2):61-8. PubMed ID: 4033559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 17. Is stimulation of prejunctional dopamine receptors an antihypertensive principle?
    Clark BJ
    Clin Exp Hypertens A; 1987; 9(5-6):1045-68. PubMed ID: 3304728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients].
    Mies R; Lang R; Weidinger G; Welzel D
    Arzneimittelforschung; 1983; 33(5):771-3. PubMed ID: 6683557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.